Covered recipient · General Payments record
NIDAL M BOUTROS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,754.84
- Reported across 298 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $565.14 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $173.12 | 13 |
| GlaxoSmithKline, LLC. | $65.76 | 4 |
| ABBVIE INC. | $65.09 | 3 |
| Daiichi Sankyo Inc. | $63.40 | 3 |
| Lilly USA, LLC | $46.03 | 2 |
| Novo Nordisk AS | $45.31 | 3 |
| Radius Health, Inc. | $34.62 | 1 |
| Acerta Pharma LLC | $30.62 | 2 |
| Sumitomo Pharma America, Inc. | $22.83 | 1 |
| Astellas Pharma US Inc | $18.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.14 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103354584 | CMS |
| ABBVIE INC. | $27.93 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103354586 | CMS |
| ABBVIE INC. | $17.02 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103354588 | CMS |
| Astellas Pharma US Inc | $18.36 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139310304 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.80 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104722343 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.82 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105639724 | CMS |
| Daiichi Sankyo Inc. | $18.46 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089402087 | CMS |
| Daiichi Sankyo Inc. | $24.95 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089402089 | CMS |
| Daiichi Sankyo Inc. | $19.99 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089402091 | CMS |
| GlaxoSmithKline, LLC. | $17.79 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115854637 | CMS |
| GlaxoSmithKline, LLC. | $15.98 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116650175 | CMS |
| GlaxoSmithKline, LLC. | $17.24 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116337203 | CMS |
| GlaxoSmithKline, LLC. | $14.75 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116429857 | CMS |
| Lilly USA, LLC | $21.20 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135177929 | CMS |
| Lilly USA, LLC | $24.83 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135250959 | CMS |
| Novo Nordisk Inc | $17.54 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096839363 | CMS |
| Novo Nordisk Inc | $13.13 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096607215 | CMS |
| Novo Nordisk Inc | $14.64 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097509958 | CMS |
| PFIZER INC. | $14.65 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131721056 | CMS |
| PFIZER INC. | $1.68 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131914269 | CMS |
| PFIZER INC. | $17.52 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131726366 | CMS |
| PFIZER INC. | $15.60 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131736484 | CMS |
| PFIZER INC. | $12.91 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131922073 | CMS |
| PFIZER INC. | $16.72 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131728947 | CMS |
| PFIZER INC. | $17.92 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131729347 | CMS |
| PFIZER INC. | $16.05 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131844678 | CMS |
| PFIZER INC. | $18.37 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131950420 | CMS |
| PFIZER INC. | $16.72 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131960292 | CMS |
| PFIZER INC. | $14.77 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132122458 | CMS |
| PFIZER INC. | $1.16 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131003378 | CMS |
| PFIZER INC. | $9.05 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131065959 | CMS |
| Radius Health, Inc. | $34.62 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089980306 | CMS |
| Sumitomo Pharma America, Inc. | $22.83 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148830355 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.